ENTITY
stringlengths 8
8
| DEFINITION
stringlengths 3
8.47k
⌀ | ALIASES
stringlengths 2
13.6k
⌀ | NAME
stringlengths 2
1.98k
|
|---|---|---|---|
C0827319 | null | Bony part of proximal metaphysis of first metatarsal bone | Bony part of proximal metaphysis of first metatarsal bone |
C0027746 | Loss of functional activity and trophic degeneration of nerve axons and their terminal arborizations following the destruction of their cells of origin or interruption of their continuity with these cells. The pathology is characteristic of neurodegenerative diseases. Often the process of nerve degeneration is studied in research on neuroanatomical localization and correlation of the neurophysiology of neural pathways. | Neurodegeneration|Nerve Degenerations|Neuron Degeneration|Degenerations, Nerve|degeneration neuron|Degenerations, Neuron|degeneration neurons|neurodegeneration|Ongoing loss of nerve cells|neuron degeneration|Neuron Degenerations|neural degeneration|Degeneration, Nerve|Progressive neurodegenerative disorder|nerve degeneration|Degeneration, Neuron|degeneration nerves | Nerve Degeneration |
C1364818 | This gene is involved in transcriptional activation and mutations in the gene are correlated with Alzheimer disease. | Amyloid Beta (A4) Precursor Protein Gene|APP gene|peptidase nexin-II|PROTEASE NEXIN II|AAA|PN2|APP Gene|CEREBRAL VASCULAR AMYLOID PEPTIDE|AMYLOID BETA A4 PRECURSOR PROTEIN|AMYLOID OF AGING AND ALZHEIMER DISEASE|APP|CVAP|amyloid beta precursor protein | APP gene |
C1364818 | This gene is involved in transcriptional activation and mutations in the gene are correlated with Alzheimer disease. | Amyloid Beta (A4) Precursor Protein Gene|APP gene|peptidase nexin-II|PROTEASE NEXIN II|AAA|PN2|APP Gene|CEREBRAL VASCULAR AMYLOID PEPTIDE|AMYLOID BETA A4 PRECURSOR PROTEIN|AMYLOID OF AGING AND ALZHEIMER DISEASE|APP|CVAP|amyloid beta precursor protein | APP gene |
C1512977 | A cell originating from or isolated from an animal of class Mammalia. | null | Mammalian Cell |
C0035693 | RNA consisting of two strands as opposed to the more prevalent single-stranded RNA. Most of the double-stranded segments are formed from transcription of DNA by intramolecular base-pairing of inverted complementary sequences separated by a single-stranded loop. Some double-stranded segments of RNA are normal in all organisms. | dsRNA|double stranded rna|dsrna|Double-Stranded (ds) RNA|Ribonucleic acid, double stranded (substance)|Double-Stranded RNA|double-stranded RNA|RNA, Double Stranded|Double Stranded RNA|Double-stranded RNA|Ribonucleic acid, double stranded|double stranded RNA | RNA, Double-Stranded |
C0006041 | A republic in southern Africa, between NAMIBIA and ZAMBIA. It was formerly called Bechuanaland. Its capital is Gaborone. The Kalahari Desert is in the west and southwest. | Bechuanaland|Botswana|BOTSWANA|BW|Botswana (geographic location)|BWA|botswana | Botswana |
C0018873 | The first continuously cultured human malignant CELL LINE, derived from the cervical carcinoma of Henrietta Lacks. These cells are used for, among other things, VIRUS CULTIVATION and PRECLINICAL DRUG EVALUATION assays. | HeLa cell|Cells, HeLa|HeLa Cells|HeLa Cell|HeLa cells|hela cells|Cell, HeLa|HeLa|hela cell | HeLa Cells |
C0006041 | A republic in southern Africa, between NAMIBIA and ZAMBIA. It was formerly called Bechuanaland. Its capital is Gaborone. The Kalahari Desert is in the west and southwest. | Bechuanaland|Botswana|BOTSWANA|BW|Botswana (geographic location)|BWA|botswana | Botswana |
C0949610 | Proteins encoded by the mitochondrial genome or proteins encoded by the nuclear genome that are imported to and resident in the MITOCHONDRIA. | Proteins, Mitochondrial|Protein, Mitochondrial|Mitochondrial Protein|mitochondrial protein|mitochondrial proteins | Mitochondrial Proteins |
C0054778 | null | cholesteryl 14-methylhexadecanoate|cholest-5-en-3 beta-ol-14-methylhexadecanoate|cholesterol 14-methylhexadecanoate | carcinolipin |
C0054778 | null | cholesteryl 14-methylhexadecanoate|cholest-5-en-3 beta-ol-14-methylhexadecanoate|cholesterol 14-methylhexadecanoate | carcinolipin |
C0534519 | A long pro-domain caspase that has specificity for the precursor form of INTERLEUKIN-1BETA. It plays a role in INFLAMMATION by catalytically converting the inactive forms of CYTOKINES such as interleukin-1beta to their active, secreted form. Caspase 1 is referred as interleukin-1beta converting enzyme and is frequently abbreviated ICE. | IL-1 beta-Converting Enzyme|Converting Enzyme, Interleukin-1beta|ICE Protease|Interleukin 1 Converting Enzyme|Convertase, IL-1 beta|Converting Enzyme, Interleukin-1|IL1BC Enzyme|Interleukin-1 Converting Enzyme|CASP1 Caspase|Caspase-1|beta Convertase, IL-1|Caspase-1 (substance)|IL 1 beta Convertase|IL 1 beta Converting Enzyme|caspase 1|Interleukin 1-beta converting enzyme|IL-1 beta Convertase|Interleukin 1beta Converting Enzyme|Caspase, CASP1|Caspase 1|Interleukin-1 beta convertase precursor|Interleukin-1beta Converting Enzyme|caspase-1|beta-Converting Enzyme, IL-1 | Caspase-1 |
C1516373 | Cellular or subcellular processes involved with significant disturbance from a homeostatic condition. (NCI) | null | Cellular Stress |
C0051318 | An IBOTENIC ACID homolog and glutamate agonist. The compound is the defining agonist for the AMPA subtype of glutamate receptors (RECEPTORS, AMPA). It has been used as a radionuclide imaging agent but is more commonly used as an experimental tool in cell biological studies. | 4-Isoxazolepropanoic acid, alpha-amino-2,3-dihydro-5-methyl-3-oxo-|alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)|ampa|AMPA|alpha-amino-3-hydroxy-5-methyl-4-isoxazoleproprionic acid|amino 3 hydroxy 5 methylisoxazole 4 propionate|alpha Amino 3 hydroxy 5 methyl 4 isoxazolepropionic Acid | alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid |
C0175412 | A part of the substantia nigra. The pars compacta nerve cells contain melanin and are involved in motor control. | Pars Compactas|PARS COMPACTA|Nigra Compactas, Substantia|pars compacta|Nigra Compacta, Substantia|Substantia nigra pars compacta|Pars Compacta|Nucleus substantiae nigrae, Pars compacta|Pars compacta substantiae nigrae|Substantia nigra, compact part|Substantia Nigra Compacta|Substantia Nigra Compactas|Pars compacta|Compact part of substantia nigra|Substantia nigra, pars compacta|Substantia Nigra Pars Compacta | Pars Compacta |
C0061465 | Cell-surface proteins that bind glutamate and trigger changes which influence the behavior of cells. Glutamate receptors include ionotropic receptors (AMPA, kainate, and N-methyl-D-aspartate receptors), which directly control ion channels, and metabotropic receptors which act through second messenger systems. Glutamate receptors are the most common mediators of fast excitatory synaptic transmission in the central nervous system. They have also been implicated in the mechanisms of memory and of many diseases. | glutamate receptor|Receptors, Glutamate|Glutamate Receptors|glutamate receptors|Glutamate Receptor|Receptor, Glutamate | Glutamate Receptor |
C0051318 | An IBOTENIC ACID homolog and glutamate agonist. The compound is the defining agonist for the AMPA subtype of glutamate receptors (RECEPTORS, AMPA). It has been used as a radionuclide imaging agent but is more commonly used as an experimental tool in cell biological studies. | 4-Isoxazolepropanoic acid, alpha-amino-2,3-dihydro-5-methyl-3-oxo-|alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)|ampa|AMPA|alpha-amino-3-hydroxy-5-methyl-4-isoxazoleproprionic acid|amino 3 hydroxy 5 methylisoxazole 4 propionate|alpha Amino 3 hydroxy 5 methyl 4 isoxazolepropionic Acid | alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid |
C1260954 | null | Morphologic alteration, NOS|Morphologic change, NOS|Body structure, altered from its original anatomical structure (morphologic abnormality)|Body structure, altered from its original anatomical structure|Morphologic alteration|changes morphologic|Morphologic change|altered from its original anatomical structure | Morphologically altered structure |
C0021747 | Proteins secreted by vertebrate cells in response to a wide variety of inducers. They confer resistance against many different viruses, inhibit proliferation of normal and malignant cells, impede multiplication of intracellular parasites, enhance macrophage and granulocyte phagocytosis, augment natural killer cell activity, and show several other immunomodulatory functions. | Product containing interferon (product)|Interferon|interferons|Interferons|Interferon-containing product|interferon|Interferon (substance)|INTERFERON|IFN | Interferons |
C0073918 | null | Saave | SAAVE |
C0073918 | null | Saave | SAAVE |
C0073918 | null | Saave | SAAVE |
C0171961 | A transcription factor and member of the nuclear receptor family NR5 that is expressed throughout the adrenal and reproductive axes during development. It plays an important role in sexual differentiation, formation of primary steroidogenic tissues, and their functions in post-natal and adult life. It regulates the expression of key steroidogenic enzymes. | FTZF1 Protein|SF 1|Steroidogenic Factor 1|SF-1 Transcription Factor|NR5A1 Protein|Ad4 Binding Protein|steroidogenic factor 1|Transcription Factor, SF-1|SF1|Nuclear Receptor 5A1 Protein|AD4BP Protein|Fushi Tarazu Factor Homolog 1|Adrenal 4 Binding Protein|Ad4-Binding Protein|Steroid Hormone Receptor Ad4BP | Steroidogenic Factor 1 |
C0153443 | A primary or metastatic malignant neoplasm that affects the rectosigmoid area. Representative examples include carcinoma, lymphoma, and sarcoma. | Malignant tumor of rectosigmoid junction (disorder)|Malignant tumour of rectosigmoid junction|Malignant tumor of rectosigmoid junction|Malignant Rectosigmoid Neoplasm|Malignant Rectosigmoid Tumor|Rectosigmoid colon cancer|Malignant Tumor of Rectosigmoid Junction|Malignant neoplasm of rectosigmoid colon|Malignant Tumor of the Rectosigmoid Junction|Malignant neoplasm of rectosigmoid|Malignant Neoplasm of Rectosigmoid Junction|Malignant neoplasm of rectosigmoid junction|Malignant Neoplasm of the Rectosigmoid Junction | Malignant tumor of rectosigmoid junction |
C0153443 | A primary or metastatic malignant neoplasm that affects the rectosigmoid area. Representative examples include carcinoma, lymphoma, and sarcoma. | Malignant tumor of rectosigmoid junction (disorder)|Malignant tumour of rectosigmoid junction|Malignant tumor of rectosigmoid junction|Malignant Rectosigmoid Neoplasm|Malignant Rectosigmoid Tumor|Rectosigmoid colon cancer|Malignant Tumor of Rectosigmoid Junction|Malignant neoplasm of rectosigmoid colon|Malignant Tumor of the Rectosigmoid Junction|Malignant neoplasm of rectosigmoid|Malignant Neoplasm of Rectosigmoid Junction|Malignant neoplasm of rectosigmoid junction|Malignant Neoplasm of the Rectosigmoid Junction | Malignant tumor of rectosigmoid junction |
C0264492 | null | Chronic respiratory failure (disorder)|Respiratory failure, chronic|chronic respiratory failure|respiratory failure chronic|Chronic respiratory failure | Chronic respiratory failure |
C0043084 | Permanent deprivation of breast milk and commencement of nourishment with other food. (From Stedman, 25th ed) | Ablactation|Infants--Weaning|wean|Weaned|Weaning, function (observable entity)|ablactation|Weaned (finding)|Weaning|Weanings|weaning|weaned|Weaning, function | Weaning |
C0020440 | A clinical manifestation of abnormal increase in the amount of carbon dioxide in arterial blood. | High blood carbon dioxide level|SERUM CARBON DIOXIDE INCREASED|Carbon dioxide, increased level|Hypercapnia, NOS|Hypercapnemia|hypercapnia|BLOOD CO2 INCREASED|PCO2 INCREASED ON ARTERIAL BLOOD GAS|CARBON DIOXIDE BLOOD INCREASED|carbon dioxide retention|HYPERCARBIA|Hypercapnia|HYPERCAPNIA|Hypercapnia (finding)|RETENTION CARBON DIOXIDE|Blood carbon dioxide level above normal|CO2 increased in blood|Blood carbon dioxide elevated|co2 retention|Hypercapnia (disorder)|hypercarbia|Hypercarbia|Hypercapnaemia|Hypercarbia, NOS|hypercapnic|Hypercapnemia, NOS | Hypercapnia |
C0035222 | A syndrome characterized by progressive life-threatening RESPIRATORY INSUFFICIENCY in the absence of known LUNG DISEASES, usually following a systemic insult such as surgery or major TRAUMA. | SYNDROME ADULT RESPIRATORY|adult rds|shock lung|ARDS|WET LUNG SYNDROME|DaNang lung|SYNDROME ADULT RESPIRATORY DISTRESS|Vietnam lung|Lung, Shock|SHOCK LUNG|RESPIRATORY DISTRESS SYNDROME|Acquired respiratory distress syndrome|ARDSs, Human|ARDs - Acute respiratory distress syndrome|Shock lung|RESPIRATORY DISTRESS SYNDROME, ADULT|Shock-lung syndrome|Adult Respiratory Distress Syndrome, ARDS|Adult respiratory distress syndrome, NOS|Adult RDS|Respiratory distress syndrome (finding)|Respiratory distress syndrome, Adult|ARDS, Human|Respiratory Distress Syndrome, Adult|Congestive atelectasis|ADULT RESPIRATORY DISTRESS SYNDROME|Adult hyaline membrane disease|wet lung syndrome|Respiratory distress syndrome, adult|Human ARDS|Pulmonary capillary leak syndrome|Acute Respiratory Distress Syndrome|Shock Lung|Respiratory distress syndrome|RESPIRATORY DISTRESS SYNDROME ADULT|ARDS - Adult respiratory distress syndrome|a.r.d.s.|Respiratory Distress Syndrome, Acute|SYNDROME RESPIRATORY DISTRESS ADULT|Adult respiratory distress syndrome|Adult Respiratory Distress Syndrome|adult respiratory syndrome|adult respiratory distress syndrome (ARDS)|Acute respiratory distress syndrome (disorder)|danang lung|ards|adult hyaline membrane disease|wet lung|a r d s|Acute respiratory distress syndrome|adult respiratory distress syndrome|DISTRESS RESPIRATORY SYNDROME ADULTS|Wet-lung syndrome, adult | Respiratory Distress Syndrome, Adult |
C0001884 | Physiologically, the opposition to flow of air caused by the forces of friction. As a part of pulmonary function testing, it is the ratio of driving pressure to the rate of air flow. | Airway Resistances|AIRRES|Resistance, Airway|Resistances, Airway|Raw|Airway Resistance|RAW | Airway Resistance Test |
C0048060 | null | 4-aminoquinoline (substance)|4-aminoquinoline|4-AMINOQUINOLINE | 4-aminoquinoline |
C0003374 | Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585) | antimalarials|Medicinal product acting as antimalarial (product)|anti malarial|Anti-Malarials|ANTIMALARIAL AGENTS|Antimalarial agent, NOS|Antimalarial Agent|Antimalarial Drugs|Anti-Malarial Agent|Anti Malarials|Antimalarial agent|antimalarial drug|Substance with antimalarial mechanism of action|Substance with antimalarial mechanism of action (substance)|Antimalarial|Antimalarial-containing product|Antimalarials|anti-malarials|antimalarial|Antimalarial Agent [TC]|Anti-Malarial Drug|anti malarials|Antimalarial Agents|Drugs, Antimalarial|antimalarial drugs|Antimalarial drug|ANTIMALARIALS|antimalarial agent|Agents, Antimalarial|antimalarial agents|Product containing antimalarial (product) | Antimalarials |
C0011145 | Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form. | Desferrioxamine|Deferoxaminum|Deferoximine|Deferrioxamine|Desferroxamine|N'-[5-[[4-[[5-(Acetylhydroxyamino)pentyl]amino]-1,4-dioxobutyl]hydroxyamino]pentyl]-N-(5-aminopentyl)-N-hydroxybutanediamide|Déferoxamine|Deferoxamine-containing product|Deferoxamine (substance)|Deferoxamine|N-[5-[3-[(5-Aminopentyl)hydroxycarbamoyl]propionamido]pentyl]-3-[[5-(N-hydroxyacetamido)pentyl]carbamoyl]propionohydroxamic Acid|Butanediamide, N'-(5-((4-((5-(acetylhydroxyamino)pentyl)amino)-1,4-dioxobutyl)hydroxyamino)pentyl)-N-(5-aminopentyl)-N-hydroxy-|desferroxamine|Deferrioxamine B|Product containing deferoxamine (medicinal product)|Deferoxamin|Deferoxamine B|DFO|desferrioxamine|DEFEROXAMINE|DFOA|deferoxamine|1-Amino-6,17-dihydroxy-7,10,18,21-tetraoxo-27-(n-acetylhydroxylamino)-6,11,17,22-tetraazaheptaeicosane|deferoximine|Desferrioxamine B|Desferioximine|DFOM|Deferoxamina | deferoxamine |
C0001047 | The N-acetyl derivative of CYSTEINE. It is used as a mucolytic agent to reduce the viscosity of mucous secretions. It has also been shown to have antiviral effects in patients with HIV due to inhibition of viral stimulation by reactive oxygen intermediates. | L-acetylcysteine|Acetylcysteine|N-acetyl-L-cysteine|n-acetyl-l-cysteine|mercapturic acid|L-Alpha-acetamido-beta-mercaptopropionic Acid|ACETYLCYSTEINE|L-Cysteine, N-acetyl-|Mercapturic Acid|N-acetylcysteine|n acetylcysteine|N-Acetyl Cysteine|acetyl cysteine|N-acetyl-3-mercaptoalanine|(R)-mercapturic acid|N-Acetyl-L-cysteine|(2R)-2-acetylamino-3-sulfanylpropanoic acid|Product containing acetylcysteine (medicinal product)|Acid, Mercapturic|N-acetyl-L-(+)-cysteine|Mercapturic acid|N Acetyl L cysteine|Acetylcysteine-containing product|acetyl cysteine l n|L-α-acetamido-β-mercaptopropionic acid|acetylcysteine|n acetyl l cysteine|Acetilcisteina|acetylcysteine n|N-Acetylcysteine|NAC|Acetyl cysteine|l cysteine n acetyl|n-acetylcysteine|Acetylcysteine (substance)|Acetylcysteinum|(R)-2-acetylamino-3-mercaptopropanoic acid|N Acetylcysteine | acetylcysteine |
C0007974 | Chemicals that bind to and remove ions from solutions. Many chelating agents function through the formation of COORDINATION COMPLEXES with METALS. | agent chelates|chelating agent|Chelating Agents|chelate agent|Agents, Chelating|Chelating agent-containing product|Chelating Agent|Product containing chelating agent (product)|agents chelating|chelators|chelator|Substance with chelating agent mechanism of action (substance)|Chelating agent|Chelates|Substance with chelating agent mechanism of action|chelating agents|Complexons|Chelators | Chelating Agents |
C0003968 | A six carbon compound related to glucose. It is found naturally in citrus fruits and many vegetables. Ascorbic acid is an essential nutrient in human diets, and necessary to maintain connective tissue and bone. Its biologically active form, vitamin C, functions as a reducing agent and coenzyme in several metabolic pathways. Vitamin C is considered an antioxidant. | Vitamin-C|L-ascorbic acid|ácido ascórbico|vitamin C|Ascorbic acid (substance)|L-Ascorbic Acid|Ascorbic acid preparation|acidum ascorbinicum|Ascorbic acid-containing product|VITAMIN C PREPARATIONS|ascorbic acid (vit C)|ascorbic acid|VIT C|Vitamin C|Vitamina C|ASCORBIC ACID|Product containing ascorbic acid (medicinal product)|acide ascorbique|Ascorbic acid|Vitamin C preparation, NOS|Acid, L-Ascorbic|L-Ascorbic acid|VITAMIN C|Ascorbinsäure|Acidum ascorbicum|Acid, Ascorbic|L Ascorbic Acid|Ascorbic Acid|vitamin-c|L-(+)-ascorbic acid|C Vitamin|2-(1,2-dihydroxyethyl)-4,5-dihydroxy-furan-3-one|C vitamin | ascorbic acid |
C0003968 | A six carbon compound related to glucose. It is found naturally in citrus fruits and many vegetables. Ascorbic acid is an essential nutrient in human diets, and necessary to maintain connective tissue and bone. Its biologically active form, vitamin C, functions as a reducing agent and coenzyme in several metabolic pathways. Vitamin C is considered an antioxidant. | Vitamin-C|L-ascorbic acid|ácido ascórbico|vitamin C|Ascorbic acid (substance)|L-Ascorbic Acid|Ascorbic acid preparation|acidum ascorbinicum|Ascorbic acid-containing product|VITAMIN C PREPARATIONS|ascorbic acid (vit C)|ascorbic acid|VIT C|Vitamin C|Vitamina C|ASCORBIC ACID|Product containing ascorbic acid (medicinal product)|acide ascorbique|Ascorbic acid|Vitamin C preparation, NOS|Acid, L-Ascorbic|L-Ascorbic acid|VITAMIN C|Ascorbinsäure|Acidum ascorbicum|Acid, Ascorbic|L Ascorbic Acid|Ascorbic Acid|vitamin-c|L-(+)-ascorbic acid|C Vitamin|2-(1,2-dihydroxyethyl)-4,5-dihydroxy-furan-3-one|C vitamin | ascorbic acid |
C0039938 | Hydrogen-donating proteins that participates in a variety of biochemical reactions including ribonucleotide reduction and reduction of PEROXIREDOXINS. Thioredoxin is oxidized from a dithiol to a disulfide when acting as a reducing cofactor. The disulfide form is then reduced by NADPH in a reaction catalyzed by THIOREDOXIN REDUCTASE. | Thioredoxin|thioredoxin|Thioredoxins | Thioredoxins |
C1518147 | A process that consists of interference with, or restraint of, activities that regulate the cellular capacity to transit the last cell cycle stage during which replicated daughter chromosomes separate into separate nuclei and cytokinesis occurs to produce separate daughter cells. | down-regulation of mitosis|downregulation of mitosis|down regulation of mitosis|negative regulation of mitosis|negative regulation of mitotic nuclear division|Mitosis Inhibition|M Phase Arrest | Negative Regulation of Mitosis |
C0003315 | A heterogeneous group of immunocompetent cells that mediate the cellular immune response by processing and presenting antigens to the T-cells. Traditional antigen-presenting cells include MACROPHAGES; DENDRITIC CELLS; LANGERHANS CELLS; and B-LYMPHOCYTES. FOLLICULAR DENDRITIC CELLS are not traditional antigen-presenting cells, but because they hold antigen on their cell surface in the form of IMMUNE COMPLEXES for B-cell recognition they are considered so by some authors. | Cell, Immunologic Accessory|Accessory Cells, Immunologic|Antigen Processing Cell|APC|Antigen-presenting dendritic cell|Cells, Immunologic Accessory|Dendritic cell|antigen-presenting cell|Immunologic Accessory Cells|antigen presenting cell|Antigen-presenting cell|accessory cell|antigen-presenting cell (APC)|Accessory Cell, Immunologic|Antigen-Presenting Cells|Antigen Presenting Cells|Antigen Presenting Cell|Antigen-Presenting Cell|Cell, Antigen-Presenting|Cells, Antigen-Presenting|Immunologic Accessory Cell|Antigen presenting cells|apc|Accessory Cell|antigen presenting cells|Antigen presenting cell|antigen-presenting cells | Antigen-Presenting Cells |
C0282639 | Human colonic ADENOCARCINOMA cells that are able to express differentiation features characteristic of mature intestinal cells such as the GOBLET CELLS. | HT-29|HT-29 Cells|HT29|HT 29 Cells|ht-29 cell|ht29 cells|Cells, HT29|Cell, HT-29|HT-29 Cell|HT29 Cell|Cell, HT29|Cells, HT-29|HT29 Cells | HT29 Cells |
C0587009 | null | Pancreas tissue sample|Tissue specimen from pancreas (specimen) | Tissue specimen from pancreas |
C0003364 | Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. | Anti Hypertensives|hypotensive agent|Anti-Hypertensive Drugs|High Blood Pressure Medicines|Hypotensive agents|Antihypertensive medicines|antihypertensive agents|Antihypertensive Agents|Antihypertensive Medicines|Antihypertensive Drugs|Antihypertensive drug, NOS|Hypotensive Agents|anti-hypertensives|Antihypertensive agent|HYPOTENSIVE AGENTS|hypotensive agents|Anti-Hypertensives|antihypertensive|Blood Pressure Medicines|Antihypertensive Agent|Anti-Hypertensive Agents|Hypotensive agent|Agents, Antihypertensive|Antihypertensives|Hypotensive agent (substance)|Agents, Anti-Hypertensive|Antihypertensive agent, NOS|ANTIHYPERTENSIVES|Drugs, Anti-Hypertensive|anti hypertensive|Anti Hypertensive Agents|anti-hypertensive drugs|antihypertensives drugs|Anti Hypertensive Drugs|anti hypertensives|Hypotensives|antihypertensive drug|anti hypertensive drug|antihypertensives|Hypotensive agent (product)|blood pressure lowering drug|Hypotensive agent, NOS|Antihypertensive drug|antihypertensive drugs|antihypertensive agent|Drugs, Antihypertensive|anti hypertensive drugs|Antihypertensive|Hypotensive Drugs|High blood pressure medicines | Antihypertensive Agents |
C0418981 | null | Medical therapy (procedure)|medical therapies|Medical therapy|medical therapy | Medical therapy |
C0597128 | agent used to reduce elevated intraocular pressure. | antiglaucoma drug | ocular hypotensive |
C0035334 | Hereditary, progressive degeneration of the retina due to death of ROD PHOTORECEPTORS initially and subsequent death of CONE PHOTORECEPTORS. It is characterized by deposition of pigment in the retina. | Pigmentary Retinopathies|Retinitis pigmentosa (RP)|Retinitis Pigmentosa|Tapetoretinal Degenerations|RETINITIS PIGMENTOSA|Retinitis pigmentosa|Retinopathies, Pigmentary|Tapetoretinal Degeneration|CHORIORETINAL HEREDODYSTROPHY|RP|rp|Retinitis pigmentosa (disorder)|retinitis pigmentosa|Tapetoretinal degeneration|Retinopathy, Pigmentary|Pigmentary Retinopathy|pigmentary retinopathy|RP - Retinitis pigmentosa|DYSTROPHY, PERIPHERAL TAPETORETINAL | Retinitis Pigmentosa |
C1384666 | Partial or complete loss of the ability to detect or understand sounds resulting from damage to the outer, middle, or inner ear structures. Causes include exposure to loud noise, ear infections, injuries to the ear, genetic, and congenital disorders. | HEARING IMPAIRMENT|Hearing loss, NOS|hearing impairment|Unspecified hearing loss|Decreased hearing|Hearing Impairment|decreased hearing|Loss, Hearing|HEARING DECREASED|Difficulty hearing|Hypoacusis|Hearing Loss|hearing impaired|Hearing defect|Hearing impaired|impaired hearing|HL - Hearing loss|Hearing loss (disorder)|Hearing deficit|Decreased hearing (finding)|HEARING IMPAIRED|Hearing impairment|Hard of hearing|Hearing deficits|Hypoacuses|Impaired hearing|HI - Hearing impairment|HEARING REDUCED|hearing impairments|Hearing loss|HEARING LOSS|HOH - Hard of hearing|Impairment, Hearing|hearing loss | hearing impairment |
C0018784 | Hearing loss resulting from damage to the COCHLEA and the sensorineural elements which lie internally beyond the oval and round windows. These elements include the AUDITORY NERVE and its connections in the BRAINSTEM. | HEARING DISORDER RETROCOCHLEAR|sensorineural hearing losses|SNHL - Sensorineural hearing loss|Perceptive deafness, NOS|Hearing Loss, Sensorineural|Sensory-neural hearing loss|SNHL|PD - Perceptive deafness|Hearing impairment, sensorineural|perceptive deafness|HEARING DISORDER, SENSORINEURAL|Sensorineural Hearing Loss|Sensorineural hearing loss, unspecified|Sensorineural hearing loss, NOS|Sensorineural hearing loss (disorder)|Hearing loss, perceptive|sensorineural deafness|Perceptive deafness|HEARING DISORDER, NEURAL|Perceptive hearing loss, NOS|hearing loss sensorineural|Deafness, sensorineural|Perceptive hearing loss|Sensorineural hearing loss|Sensorineural deafness|Neurosensory deafness|sensory hearing loss|sensory neuro deafness|Sensorineural Deafness|Sensorineural deafness syndrome|SND - Sensorineural deafness|Sensory-neural deafness|sensorineural hearing loss|Deafness Sensorineural|Hearing loss, sensorineural|Perceptive hearing loss or deafness|DEAFNESS, PERCEPTIVE|inner ear hearing loss|hearing loss sensori neural|Sensorineural hearing impairment | Sensorineural Hearing Loss (disorder) |
C0422943 | null | Visual symptoms (finding) | Visual symptoms |
C0547030 | An interference to normal eyesight. | Visual alteration|Disturbances, Visual|visual disturbance|Visual disturbance|Visual disturbance, NOS|disturbances visuals|disturbances visual|Visual Alteration|dysopia|Visual Disturbance|Visual alteration (finding)|visual disturbances|VISUAL DISTURBANCE|Visual disturbance (disorder)|Visual Disturbances|disturbance visual|Unspecified visual disturbance|Visual disturbances | Visual disturbance |
C0260073 | null | Surgical ophthalmologist|Ophthalmic surgeon (occupation)|Ophthalmic surgeon | Ophthalmic surgeon |
C0009195 | The part of the inner ear (LABYRINTH) that is concerned with hearing. It forms the anterior part of the labyrinth, as a snail-like structure that is situated almost horizontally anterior to the VESTIBULAR LABYRINTH. | Cochleal|Cochleas|Cochlear Organ|Cochlear|cochlea|Cochlea, NOS|Cochlea|Cochlear structure (body structure)|EAR, COCHLEA|Cochlear part of bony labyrinth|Cochlear structure | Cochlear structure |
C0036690 | Systemic disease associated with the presence of pathogenic microorganisms or their toxins in the blood. | Blood Poisoning|toxemia|Septicemia|Septicemia NOS|Poisoning, Blood|sepsis|Unspecified septicemia|Blood Poisonings|Systemic Sepsis|Sepsis Syndrome|Septicemia, NOS|SEPTICEMIA|Poisonings, Blood|Sepsis|blood poisoning|poisoning blood|Septicemias|septicaemia|Infection in blood stream|Septicaemia, NOS|Blood poisoning, NOS|BLOOD POISONING|septicemia | Septicemia |
C0086660 | null | Murders|murdered|murders|Assassination NOS|Murder (event)|MURDER|Murder NOS|assassination|murder|Murder, NOS|Murder | Murder |
C0282350 | to treat someone else in a harmful or injurious manner involving sex. | SA - Sexual abuse|Abuses, Sexual|sexual abuses|abuse sex|Sexual abuse (event)|Sexual abuse|Sexual Abuse|Abuse, Sexual|abuse sexual|sexual abuse|Sexual Abuses|sex abuse | Sexual abuse |
C0038239 | A tough, malleable, iron-based alloy containing up to, but no more than, two percent carbon and often other metals. It is used in medicine and dentistry in implants and instrumentation. | steel|Steel|Steels|steeling|steels | Steel |
C0013879 | Substances that comprise all matter. Each element is made up of atoms that are identical in number of electrons and protons and in nuclear charge, but may differ in mass or number of neutrons. | Chemical element, NOS|Chemical element|Element, chemical|Elements|Chemical elements|chemical elements|Element, NOS|element|Chemical element (substance)|elements|Element | Elements |
C0134796 | null | p-nitrophenol phosphate|4-nitrophenyl phosphate|p-nitrophenyl phosphate | 4-nitrophenylphosphate |
C0038410 | A gram-positive organism found in the upper respiratory tract, inflammatory exudates, and various body fluids of normal and/or diseased humans and, rarely, domestic animals. | Pneumococcus|Pneumococcal|STREPTOCOCCUS PNEUMONIAE|pneumococcus|s. pneumoniae|streptococcus pneumoniae|S. pneumoniae|Streptococcus pneumoniae (organism)|Streptococcus pneumoniae|Micrococcus pneumoniae|streptococcus pneumoniae bacteria|pneumococcal|Diplococcus pneumoniae|diplococcus pneumoniae | Streptococcus pneumoniae |
C0011185 | A substance being studied in the prevention of cancer. It is a type of steroid. | 3-beta-hydroxy-5-androsten-17-one|Dehydroandrosterone|dehydroisoandrosterone|Dehydroepiandrosterone|Androstenolone|3β-hydroxyandrost-5-en-17-one|Dehydroepiandrosterone (substance)|5-Androsten-3-beta-hydroxy-17-one|Dehydroisoandrosterone|17-Hormoforin|Androst-5-en-17-one, 3-hydroxy-, (3beta)-|3beta-hydroxyandrost-5-en-17-one|DEHYDROEPIANDROSTERONE|dehydroepiandrosterone (DHEA)|Prasterone|PRASTERONE|dehydroepiandrosterone|DHEA|Dehydroepiandrosterone-containing product|prasterone|androstenolone|Therapeutic Dehydroepiandrosterone|therapeutic dehydroepiandrosterone|5 Androsten 3 beta hydroxy 17 one|3beta-Hydroxyandrost-5-en-17-one|DHA - Dehydroepiandrosterone|dheas|Product containing dehydroepiandrosterone (medicinal product)|DHEA - Dehydroepiandrosterone|dhea|Dehydroepiandrosterone (DHA)|5,6-Dehydroisoandrosterone|Dehydro-3-epiandrosterone | prasterone |
C0041536 | A lipid-soluble benzoquinone which is involved in ELECTRON TRANSPORT in mitochondrial preparations. The compound occurs in the majority of aerobic organisms, from bacteria to higher plants and animals. | vitamin Q10|COENZYME Q10|co-enzyme Q10|2,3-dimethoxy-5-methyl-6-decaprenylbenzoquinone|CoQ10|Co-Q10|ubidecarenone|coenzyme q10|UBIDECARENONE|coenzyme q|ubiquinone Q10|coenzyme-Q10|Coenzyme Q|Ubidecarenone|Bio-Quinone Q10|q10 ubiquinone|coenzyme-q|ubiquinone|CoQ 10|coenzyme Q10|Ubidecarenone-containing product|Ubiquinone|coenzyme-Q|coenzyme Q|Q10|Product containing ubidecarenone (medicinal product)|Ubiquinones|Coenzyme Q-10|coq10|ubiquinone 50|2-(3,7,11,15,19,23,27,31,35,39-Decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecanyl)-5,6-dimethoxy-3-methyl-2,5-cyclohexadiene-1,4-dione|q10 coenzyme|coq 10|Ubidecarenone (substance)|Coenzyme Q10|coenzymes q10|ubiquinones | ubidecarenone |
C0035142 | Any DNA sequence capable of independent replication or a molecule that possesses a REPLICATION ORIGIN and which is therefore potentially capable of being replicated in a suitable cell. (Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed) | Replicons|Genetic replication (finding)|Unit, Replication|Replicon|Replication Units|genetic replication|Units, Replication|replicon|Genetic replication|Replication Unit | Replicon |
C0038420 | A genus of bacteria that form a nonfragmented aerial mycelium. Many species have been identified with some being pathogenic. This genus is responsible for producing a majority of the ANTI-BACTERIAL AGENTS of practical value. | Kitasatoa|STREPTOMYCES|Chainia|Streptomyces|streptomyces|Streptomyces, NOS|Streptomyces species|Genus Streptomyces (organism)|Genus Streptomyces | Streptomyces |
C0315158 | A species of gram-positive, cellulolytic bacteria in the family Clostridiaceae. It produces CELLULOSOMES which are involved in plant CELL WALL degradation. | Clostridium cellulovorans|Clostridium cellulovorans (organism) | Clostridium cellulovorans |
C1260229 | A family of glycosidases that hydrolyse crystalline CELLULOSE into soluble sugar molecules. Within this family there are a variety of enzyme subtypes with differing substrate specificities that must work together to bring about complete cellulose hydrolysis. They are found in structures called CELLULOSOMES. | null | Cellulases |
C0007068 | null | carbose|Carboxymethyl cellulose|Carmellose (substance)|carboxymethyl cellulose|Carmellose-containing product|Carmelosa|Product containing carmellose (medicinal product)|Carboxymethyl Cellulose|CARBOXYMETHYLCELLULOSE|Cellulose, Carboxymethyl|Carmellose|carboxymethylcellulose|Carbose|carmellose|Cellulose carboxymethyl ether|Cellulose, carboxymethyl ether|Thylose|Carboxymethylcellulose-containing product|thylose|Carboxymethylcellulose | carboxymethylcellulose |
C0025249 | Lipids, predominantly phospholipids, cholesterol and small amounts of glycolipids found in membranes including cellular and intracellular membranes. These lipids may be arranged in bilayers in the membranes with integral proteins between the layers and peripheral proteins attached to the outside. Membrane lipids are required for active transport, several enzymatic activities and membrane formation. | Lipids, Membrane|Membrane lipid|Membrane lipids|Cell Membrane Lipids|membrane lipid|Membrane lipid (substance)|Lipids, Cell Membrane|Membrane Lipids, Cell | Membrane Lipids |
C0004755 | A plant genus of the family POACEAE. The EDIBLE GRAIN, barley, is widely used as food. | hordeum|Hordeum|Hordeum, NOS|BARLEY|Barley|barleys|Hordeum (organism) | Hordeum |
C0007648 | A polysaccharide with glucose units linked as in CELLOBIOSE. It is the chief constituent of plant fibers, cotton being the purest natural form of the substance. As a raw material, it forms the basis for many derivatives used in chromatography, ion exchange materials, explosives manufacturing, and pharmaceutical preparations. | CELLULOSE|celluloses|cellulose|Polyanhydroglucuronic Acid|alpha Cellulose|Product containing cellulose (medicinal product)|Cellulose (substance)|.ALPHA.-CELLULOSE|alpha-Cellulose|Acid, Polyanhydroglucuronic|Cellulose|Cellulose-containing product|ALPHA CELLULOSE | cellulose |
C0164456 | null | callose|calloses | callose |
C0752535 | null | null | Cellobiohydrolase II |
C0072131 | null | L-Prolylglycine dipeptidase|Prolyl dipeptidase|prolyl-alanylpeptidylhydrolase|prolinase|prolyl dipeptidase|L-prolylglycine dipeptidase|Prolinase|Imidodipeptidase|Prolyl dipeptidase (substance)|iminodipeptidase | Pro-X dipeptidase |
C0009325 | A polypeptide substance comprising about one third of the total protein in mammalian organisms. It is the main constituent of SKIN; CONNECTIVE TISSUE; and the organic substance of bones (BONE AND BONES) and teeth (TOOTH). | Collagens|Collagen (substance)|Collagen|collagen|Collagen-containing product|Product containing collagen (medicinal product)|collagens | collagen |
C0075184 | null | starch polymer hydrogel|copolymer starch hydrogel | starch hydrogel copolymer |
C0075184 | null | starch polymer hydrogel|copolymer starch hydrogel | starch hydrogel copolymer |
C0018681 | The symptom of PAIN in the cranial region. It may be an isolated benign occurrence or manifestation of a wide variety of HEADACHE DISORDERS. | Cranial Pains|head pained|HEAD PAIN CEPHALGIA|head pains|head ache|PAIN HEAD|pain in head|Headaches|Cephalgia|headaches|HEADACHE|head pain|cephalodynia|Pains, Cranial|Cephalalgia|Cephalodynias|ha|Pain, Cranial|Headache, NOS|Pain in head|cephalalgia|cranial pain|HA - Headache|CEPHALALGIA|CEPHALGIA|Headache|ache head|Cephalodynia|Head Pain|headache, cephalalgia|Head pain|Headache (finding)|cephalgias|HEAD ACHE|Pain in head NOS|Head Pains|Pain, Head|HEAD PAIN|Cephalalgias|headache|Cranial Pain|Cephalgias|Pains, Head|cephalgia | Headache |
C0006094 | The first and largest artery branching from the aortic arch. It distributes blood to the right side of the head and neck and to the right arm. | Brachiocephalic Artery|Brachiocephalic trunk|artery innominate|brachiocephalic trunk|innominate artery|Innominate artery|Trunks, Brachiocephalic|BRACHIOCEPHALIC ARTERY|Trunk, Brachiocephalic|Brachiocephalic artery|Structure of brachiocephalic artery (body structure)|artery brachiocephalic|Innominate Arteries|Structure of brachiocephalic artery|ARTERY, BRACHIOCEPHALIC|Brachiocephalic Trunk|Truncus brachiocephalicus|Brachiocephalic Trunks|Artery, Innominate|Innominate Artery|Arteries, Innominate|brachiocephalic artery | Structure of brachiocephalic artery |
C0004623 | Infections by bacteria, general or unspecified. | bacteria caused disease|Bacterial Infectious Disease|Bacterial Disorder|Bacterial infection; unspecified site|bacterial infectious diseases|bacterial diseases|Bacterial Infections|Bacterial infection by site (disorder)|Infections, Bacterial|bacterial infections|Disease caused by bacteria|Bacterial Infection|Bacterial infectious disease|other bacterial infection|Infection, Bacterial|Bacterial disease|Bacterial infection|BACTERIAL INFECTIOUS DISEASES|Diseases Caused by Bacteria|disease caused by bacteria|Bacterial Disease|bacterial infection|Bacterial infectious disease, NOS|INFECTION BACTERIAL|Bacterial infection, NOS|BACTERIAL INFECTIOUS DISEASES: GENERAL TERMS|Bacterial infection by site|bacteria caused diseases|Bacterial diseases|bacterial disease|Bacterial infections|Bacterial infectious disease (disorder)|Disease caused by bacteria, NOS | Bacterial Infections |
C0235896 | A finding indicating the presence of an inflammatory or neoplastic cellular infiltrate in the lung parenchyma. | PULMONARY INFILTRATE|lung infiltration|Pulmonary infiltrates|Infiltrate of lung (finding)|infiltration lungs|PULMONARY INFILTRATION|Lung infiltrates|pulmonary infiltrate|infiltration lung|infiltrates pulmonary|Pulmonary infiltrate|Pulmonary infiltrate NOS|Lung Infiltrate|Pulmonic infiltration|pulmonary infiltration|Infiltrate of lung|Pulmonary Infiltrate | Pulmonary Infiltrate |
C0017066 | An ACYCLOVIR analog that is a potent inhibitor of the Herpesvirus family including cytomegalovirus. Ganciclovir is used to treat complications from AIDS-associated cytomegalovirus infections. | Ganciclovirum|9-[(1,3-Dihydroxy-2-propoxy)methyl]guanine|DHPG|2-amino-9-(2-hydroxy-1-hydroxymethylethoxymethyl)-6,9-dihydro-1H-6-purinone|2'NDG|2'-Nor-2'-deoxyguanosine|2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-1H-purin-6(9H)-one|Ganciclovir (substance)|Ganciclovir-containing product|2-Amino-1,9-[[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl]-6H-purin-6-one|Gancyclovir|Product containing ganciclovir (medicinal product)|2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-9H-purin-6-ol|ganciclovir|2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-3H-purin-6(9H)-one|9-[(1,3-dihydroxy-2-propoxy)methyl]guanine|2-Amino-9-(2-hydroxy-1-hydroxymethyl-ethoxymethyl)-1,9-dihydro-purin-6-one|2-(6-Amino-purin-9-ylmethoxy)-propane-1,3-diol|Ganciclovir|dihydroxypropoxymethylguanine|9-((2-Hydroxy-1-(hydroxymethyl)ethoxy)methyl)guanine|GANCICLOVIR|Nordeoxyguanosine|GCV|GA2|gancyclovir|6H-Purin-6-one, 2-amino-1,9-dihydro-9-((2-hydroxy-1-(hydroxymethyl)ethoxy)methyl)- | ganciclovir |
C0070895 | An antiviral agent used in the treatment of cytomegalovirus retinitis. Foscarnet also shows activity against human herpesviruses and HIV. | Phosphinecarboxylic acid, dihydroxy-, oxide|Phosphonomethanoic acid|Foscarnet (substance)|Foscarnet|phosphonoformic acid|Product containing foscarnet (medicinal product)|Foscarnet-containing product|Carboxyphosphonic Acid|foscarnet|Carboxyphosphonic acid|FOSCARNET|Phosphonoformic acid|Phosphonoformic Acid|Foscarmet | foscarnet |
C1284011 | It lies laterally to intermediate mesoderm. | Plate Mesoderms, Lateral|Plate Mesoderm, Lateral|Lateral plate mesoderm (body structure)|Lateral Plate Mesoderms|Mesoderms, Lateral Plate|Mesoderm, Lateral Plate|Lateral plate mesoderm | Lateral Plate Mesoderm |
C1279572 | null | Entire left knee (body structure)|Entire left knee | Entire left knee |
C0278259 | null | Local excision (procedure)|Local excision, NOS|local excision|Excision, local (of lesion, organ, structure or tissue)|Local resection|Local resection, NOS | Local excision |
C0080306 | Mechanical devices inserted in the inferior vena cava that prevent the migration of blood clots from deep venous thrombosis of the leg. | Vena cava filter|Vena Cava Filters|FILTER, INTRAVASCULAR, CARDIOVASCULAR|vena cava filter|Cava Filter, Vena|Filter, Inferior Vena Cava|Filters, Vena Cava|Inferior Vena Cava Filters|Cava Filters, Vena|Filter, Vena Cava|Vena cava filter (physical object)|inferior vena cava filter|Filters, Inferior Vena Cava|filter vena cava inferior|inferior vena cava filters|vena cava filters|Inferior Vena Cava Filter|cava filter vena|Vena Cava Filter | Vena Cava Filters |
C0149871 | The formation of a blood clot in a deep vein of the leg or lower pelvis. Symptoms may include pain, swelling, warmth, and redness in the affected area. | DEEP VEIN THROMBOSIS|dvt|Thrombosis, Deep-Vein|Thromboses, Deep Vein|deep vein thrombosis|Thrombosis, Deep Vein|Deep vein thrombosis NOS|deep vein thromboses|Thromboses, Deep-Vein|deep vein thrombosis (DVT)|Deep Vein Thromboses|Thrombosis, Deep Venous|deep venous thromboses|Thromboses, Deep Venous|Deep Venous Thrombosis|Deep venous thrombosis (disorder)|DVT|Deep-Venous Thromboses|Venous Thromboses, Deep|Venous Thrombosis, Deep|THROMBOSIS VENOUS DEEP|Deep Vein Thrombosis (DVT)|Vein Thromboses, Deep|Vein Thrombosis, Deep|Deep Venous Thromboses|Thrombosis, Deep-Venous|Deep vein thrombosis|Multiple deep venous thrombosis|Deep-Vein Thromboses|Thromboses, Deep-Venous|DVT NOS|DVT - Deep vein thrombosis|Deep Vein Thrombosis|deep-vein thrombosis|Deep-Venous Thrombosis|deep venous thrombosis|Blood clot in a deep vein|Deep venous thrombosis|Deep-Vein Thrombosis | Deep Vein Thrombosis |
C0000768 | Malformations of organs or body parts during development in utero. | DEFECT/DEFORMITY, CONGENITAL|dysgenesis|Congenital Defects|Congenital malformation|Malformation|Congenital Malformation|Developmental defect|Developmental Malformations|Congenital abnormality|congenital abnormality|Dysgenesis|Malformation, NOS|DEVELOPMENTAL ABNORMALITY|Congenital deformity (morphologic abnormality)|dysmorphism|Congenital Deformity|Congenital defect, NOS|Deformity/Defect, Congenital|Defect, Birth|CONGENITAL ANOMALY, NOS|Developmental malformation, NOS|Congenital Anomaly|Developmental anomaly (morphologic abnormality)|Deformity|Developmental defect, NOS|CONGENITAL ANOMALY NOS|congenital defects|ANOMALY ANOMALY CONGEN|Developmental malformation|CM - Congenital malformation|Congenital Anomaly or Birth Defect|congenital defect|deformity|birth defect|Congenital defect|Abnormalities|Congenital Abnormalities|Congenital deformity|Congenital Abnormality|Fetal malformation|congenital malformations|fetal anomaly|Defects, Congenital|CONGENITAL ANOMALIES|Developmental anomaly, NOS|fetal malformation|Congenital anomaly, NOS|Defects, Birth|congenital malformation|Congenital Malformations|birth defects|Developmental Malformation|ABNORMAL DEVELOPMENT|Foetal malformation|Dysgenesis, NOS|Defect/Deformity, Congenital|BIRTH DEFECTS|Fetal developmental abnormality|Abnormality, Congenital|Anomalous formation, NOS|Deformities|congenital anomaly|malformation|dysmorphisms|CONGENITAL ANOMALY|Congenital Anatomical Abnormality|ANOMALY CONGENITAL|developmental defect|Birth Defects|Birth Defect|Developmental abnormality|Congenital abnormality, NOS|Foetal developmental abnormality|congenital abnormalities|Congenital malformation (disorder)|Congenital deformity (disorder)|Abnormal development, NOS|abnormal development|Abnormalities, Congenital|Congenital malformation, NOS|Developmental anomaly|Birth defect|Congenital Defect/Deformity|malformations|Congenital deformity, NOS|Congenital Anomalies of Fetus|Congenital Defect|Congenital anomaly, unspecified|congenital deformity|Defect, Congenital|Congenital anomaly|Congenital anomalies|Abnormal development|SCONG|CONGENITAL DEFECT/DEFORMITY|Congenital Anatomic Abnormality|congenital anomalies|Anomalous formation | Congenital Abnormality |
C0224522 | Cells on the luminal surface of the SYNOVIAL MEMBRANE. Type A synoviocytes are MACROPHAGES responsible for waste removal from the joint cavity. Fibroblast-like type B synoviocytes are involved in production of joint matrix constituents (e.g., HYALURONAN; COLLAGEN; and FIBRONECTIN). | Synovial Cells|synoviocytes|synovial cell|Synovial Cell|Synoviocytes (cell)|Hyaluronic acid secreting cell|Synoviocytes|Synoviocyte|Synovial cell|synoviocyte | Synoviocytes |
C0297666 | null | SB-203580|SB203580 | SB 203580 |
C0063659 | null | Insulin, 8A-L-threonine-10A-L-isoleucine-19A-L-phenylalanine-|insulin, phenylalanine(A19)-|A19-phenylalanine-insulin|A19-Phe-insulin | insulin, Phe(A19)- |
C0063659 | null | Insulin, 8A-L-threonine-10A-L-isoleucine-19A-L-phenylalanine-|insulin, phenylalanine(A19)-|A19-phenylalanine-insulin|A19-Phe-insulin | insulin, Phe(A19)- |
C0581366 | Repeated infections of the urinary bladder. [HPO:probinson, PMID:20639019] | Recurrent cystitis (disorder)|cystitis recurrent|Recurrent bladder infections|recurrent cystitis|Recurrent cystitis | Recurrent cystitis |
C1537007 | A type of diffusion-weighted magnetic resonance imaging (DW-MRI) that maps the diffusion of water in three dimensions, the principal purpose of which is to image the white matter of the brain, specifically measuring the anisotropy, location, and orientation of the neural tracts, which can demonstrate microstructural changes or differences with neuropathology and treatment. | Diffusion tensor imaging|DTI|DT-MRI|DTI MRI|DIFFUSION TENSOR MRI|Diffusion Tensor Magnetic Resonance Imaging|MRI, Diffusion Tensor|diffusion tensor imaging|Diffusion Tensor MRIs|Diffusion Tensor MRI|Imaging, Diffusion Tensor|Diffusion Tensor Imaging | Diffusion Tensor Imaging |
C1523478 | A proteinaceous scaffold associated with fission yeast chromosomes during meiotic prophase. Linear elements consist of a protein complex, LinE, with four main structural components (Rec10, Rec25, Rec27, and Mug20 in S. pombe) associated with chromatin. The resulting structure is related to but not equivalent to the synaptonemal complex. [DOI:10.2323/jgam.28.263, GOC:jb, PMID:12665553, PMID:30640914] | null | linear element |
C0004286 | The testing of the acuity of the sense of hearing to determine the thresholds of the lowest intensity levels at which an individual can hear a set of tones. The frequencies between 125 and 8000 Hz are used to test air conduction thresholds and the frequencies between 250 and 4000 Hz are used to test bone conduction thresholds. | Audiometric test, NOS|Audiometry|audiometric testing|audiometric test|Audiometries|AUDIOMETRY|Hearing Test|audiometry|audiometry test|audiometry tests|Audiometry, NOS|Audiometric test (procedure)|audiometry testing|Audiometric test|Audiometric Test | Audiometry |
C0013443 | The hearing and equilibrium system of the body. It consists of three parts: the EXTERNAL EAR, the MIDDLE EAR, and the INNER EAR. Sound waves are transmitted through this organ where vibration is transduced to nerve signals that pass through the ACOUSTIC NERVE to the CENTRAL NERVOUS SYSTEM. The inner ear also contains the vestibular organ that maintains equilibrium by transducing signals to the VESTIBULAR NERVE. | Ears|Vestibulocochlear organ|System, Vestibulocochlear|ears|EAR|ear|Apparatus, Vestibulocochlear|ear structure|Vestibulocochlear Apparatus|Auris|auris|Organum vestibulocochleare|Ear-related structure|Ear|Ear structure|Ear structure (body structure)|hearing apparatus|Vestibulocochlear System|ear structures | Ear structure |
C0521395 | null | Astrocytic | astrocytic |
C0021027 | Multi-subunit proteins which function in IMMUNITY. They are produced by B LYMPHOCYTES from the IMMUNOGLOBULIN GENES. They are comprised of two heavy (IMMUNOGLOBULIN HEAVY CHAINS) and two light chains (IMMUNOGLOBULIN LIGHT CHAINS) with additional ancillary polypeptide chains depending on their isoforms. The variety of isoforms include monomeric or polymeric forms, and transmembrane forms (B-CELL ANTIGEN RECEPTORS) or secreted forms (ANTIBODIES). They are divided by the amino acid sequence of their heavy chains into five classes (IMMUNOGLOBULIN A; IMMUNOGLOBULIN D; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M) and various subclasses. | Igs - Immunoglobulins|immunoglobulin|Immunoglobulins|immune globulins|GLOBULIN,IMMUNE|IG, unspecified formulation|IMMUNOGLOBULINS|Antibody|Ig|Immune Globulin|Globulins, Immune|Immune Globulins|immunoglobulin structure|Immunoglobulin|Immunoglobulin structure (substance)|Immunoglobulin (substance)|IG|IG, NOS|Product containing immunoglobulin (product)|immune globulin, unspecified formulation|immunoglobulins|Immunoglobulins / Antibodies|immune globulin|Immunoglobulin-containing product|Immunoglobulin structure|Immunoglobulin, NOS | Immunoglobulins |
C0021699 | A protein that is an integral membrane protein with a transmembrane region. | Membrane Proteins, Integral|Cell transmembrane protein|Integral Membrane Protein|Intrinsic Membrane Protein|Membrane Protein, Integral|Transmembrane Protein|Plasma transmembrane protein|Protein, Integral Membrane|Proteins, Integral Membrane|Transmembrane protein | Integral Membrane Proteins |
Subsets and Splits
No saved queries yet
Save your SQL queries to embed, download, and access them later. Queries will appear here once saved.